Combining molecular engineering and multi-scale fabrication to innovate new biomaterials for medicine and biology

My research program will utilize multi-scaled (nano, micro, and macro) fabrication techniques, combined with molecule engineering and cellular and molecular biology, to develop functional platforms of implantable devices tailored for applications in immunology, regenerative medicine, and disease monitoring.

Overview of Research Program

Background: The role of implanted biomaterials and devices in modern medicine is rapidly expanding, but their efficacy is often compromised by host immune recognition and subsequent foreign body responses. Recent discoveries on physical properties (geometry, surface porosity, mechanical stiffness) and chemical properties (molecular surface engineering, reducing protein fouling, and biomolecule displays) that can modulate host immune responses are now creating new opportunities to innovate novel, long-term functioning implantable systems for a broad spectrum of clinical applications, including cell transplantation, localized controlled drug release, continuous sensing and monitoring of physiological conditions, and tissue regeneration. While significant progress has been made, the clinical translation of these applications are still hindered by a lack of suitable biomaterials that can appropriately interact with the host immune system in a controlled and tailored manner. To achieve these goals, it will be necessary to; 1) expand our understanding of the interplay between materials properties and their influence on host immune responses, 2) based on discoveries, develop new materials with tailored properties to control host immune cell behavior, and 3) develop tools to non-invasively track cellular and biomolecular activity in vivo.

Disease Indications

click image to enlarge

Platform Technology Development

click image to enlarge

In the Veiseh lab, we are motivated to tackle the development of treatments for a range of debilitating diseases including heart disease, cancer, diabetes, and many more.

Our lab leverages the latest techniques in chemical biology, cell engineering, synthetic biology, and multi-scale device fabrication to innovate transformative solutions for intractable diseases. We are advancing these innovations rapidly towards clinical testing to provide patients with more therapeutic options.